Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 534.00
Ask: 538.00
Change: -4.00 (-0.74%)
Spread: 4.00 (0.749%)
Open: 550.00
High: 550.00
Low: 532.00
Prev. Close: 540.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury launches new book by Katherine Rundell

14 Sep 2023 07:00

RNS Number : 3709M
Bloomsbury Publishing PLC
14 September 2023
 

 

Bloomsbury launches new book by Katherine Rundell, described as "the heir to C.S. Lewis and J.R.R. Tolkien"

 

 

14 September, LONDON: Bloomsbury, the leading independent publisher, today launches one of the year's most eagerly anticipated children's novels, Impossible Creatures by Katherine Rundell.

 

Impossible Creatures is the first in a career-defining, landmark fantasy trilogy from the winner of the Costa, Baillie Gifford, British Book Award, Blue Peter and Waterstones Children's Book Prizes.

 

As well as publishing hardback and ebook formats, the novel will also be launched as an audiobook, narrated by the renowned actor Samuel West, best known for his roles in All Creatures Great and Small and Mr Selfridge.

 

On the back of a major publicity campaign the novel is set to be a bestseller.

 

The Times (Saturday 9 September) selects the novel as its Children's Book of the Week and leads with the headline "Katherine Rundell the heir to C.S. Lewis and J.R.R. Tolkien?" It continues, "the action is gripping and every sentence sparkles in this excellent first volume of a new fantasy trilogy".

 

The Sunday Times (Sunday 10 September) in the headline of its book review writes "Katherine Rundell, a brilliant children's writer to rival J.K. Rowling".

 

Bloomsbury has seen the highest ever level of pre-orders for a Katherine Rundell hardback, already exceeding her previous biggest first week sale of The Golden Mole.

 

Impossible Creatures has also been selected by Bookshop.org as its Children's Book of the Month for September.

 

Since the pandemic the sci-fi and fantasy genre has been soaring and according to data from Nielsen Bookscan, female authors now dominate the bestseller lists.

 

Nigel Newton, Chief Executive of Bloomsbury Publishing Plc, commented: "As stated in recent trading updates and results announcements, the phenomenal demand for fantasy fiction has helped drive record sales. Bloomsbury has a rich tradition in this genre and we have high expectations for Katherine Rundell to continue this trend. We are naturally overjoyed to see such widespread excitement around her latest novel."

 

-ENDS-

 

For further information please contact:

 

Hudson Sandler

 

+44 (0) 20 7796 4133

Dan de Belder/Emily Brooker

 

bloomsbury@hudsonsandler.com

 

 

Bloomsbury Publishing Plc

Bloomsbury is a leading independent publisher of fiction, non-fiction, children's, specialist, academic and professional titles, listed on the London Stock Exchange. It is one of the few publishers with a portfolio that includes both general and academic publishing. Bloomsbury's ambitious growth story has seen the Group become a significant global publisher with offices in the UK, US, Australia and India.

 

Katherine Rundell is a bestselling author whose novels for children include Rooftoppers, The Wolf Wilder, The Explorer and The Good Thieves for which she has won the Costa Children's Book Award, the Blue Peter Book Award and the Waterstones Children's Book Prize, amongst many others. She was a 2021 World Book Day author and has also published two picture books for children and three non-fiction books for adults, including Super-Infinite: The Transformations of John Donne, winner of the Baillie Gifford Prize and The Golden Mole and Other Living Treasure, shortlisted for the Waterstones Book of the Year. Her books have sold over 2 million copies internationally.

Rundell spent her childhood in Africa and Europe before taking her degree at the University of Oxford. She is a Quondam Fellow of All Souls College and a Fellow of St Catherine's College, Oxford, where she works on Renaissance literature. Very occasionally she goes climbing across the rooftops, late at night.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKNDFSFDEFA
Date   Source Headline
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.